skip to content
Covid-19 virus
COVID-19 Resources

Reliable information about the coronavirus (COVID-19) is available from the World Health Organization (current situation, international travel). Numerous and frequently-updated resource results are available from this WorldCat.org search. OCLC’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus issues in their communities.

Image provided by: CDC/ Alissa Eckert, MS; Dan Higgins, MAM
Emollient treatments for atopic dermatitis : a review of clinical effectiveness, cost-effectiveness, and guidelines Preview this item
ClosePreview this item
Checking...

Emollient treatments for atopic dermatitis : a review of clinical effectiveness, cost-effectiveness, and guidelines

Author: Ron Pohar; Suzanne McCormack, (Research information specialist); Canadian Agency for Drugs and Technologies in Health. Rapid Response Service,
Publisher: Ottawa : Canadian Agency for Drugs and Technologies in Health, January 14, 2019.
Series: Rapid response report (Canadian Agency for Drugs and Technologies in Health).
Edition/Format:   eBook : Document : English : Version 1.0
Summary:
The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn recognition from the Eczema Society as an accepted choice for people with sensitive skin." This report aimed to summarize the evidence regarding the clinical effectiveness, cost-effectiveness and guidelines of emollient treatments with "Seal of Acceptance" from the Eczema Society of Canada for atopic dermatitis.  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Review
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Ron Pohar; Suzanne McCormack, (Research information specialist); Canadian Agency for Drugs and Technologies in Health. Rapid Response Service,
OCLC Number: 1130695297
Description: 1 online resource (1 PDF file (21 pages)) : illustrations.
Series Title: Rapid response report (Canadian Agency for Drugs and Technologies in Health).
Responsibility: Ron Pohar, Suzanne McCormack.

Abstract:

The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn recognition from the Eczema Society as an accepted choice for people with sensitive skin." This report aimed to summarize the evidence regarding the clinical effectiveness, cost-effectiveness and guidelines of emollient treatments with "Seal of Acceptance" from the Eczema Society of Canada for atopic dermatitis. However, no evidence of cost-effectiveness was identified specific to these products, so only evidence of clinical effectiveness and guidelines are reported.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/1130695297<\/a>> # Emollient treatments for atopic dermatitis : a review of clinical effectiveness, cost-effectiveness, and guidelines<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Book<\/a>, schema:MediaObject<\/a>, schema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"1130695297<\/span>\" ;\u00A0\u00A0\u00A0\nlibrary:placeOfPublication<\/a> <http:\/\/id.loc.gov\/vocabulary\/countries\/onc<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/practice_guidelines_as_topic<\/a>> ; # Practice Guidelines as Topic<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/treatment_outcome<\/a>> ; # Treatment Outcome<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/dermatitis_atopic_therapy<\/a>> ; # Dermatitis, Atopic--therapy<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Place\/canada<\/a>> ; # Canada.<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/cost_benefit_analysis<\/a>> ; # Cost-Benefit Analysis<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/emollients_therapeutic_use<\/a>> ; # Emollients--therapeutic use<\/span>\n\u00A0\u00A0\u00A0\nschema:author<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Person\/mccormack_suzanne_research_information_specialist<\/a>> ; # (Research information specialist) Suzanne McCormack<\/span>\n\u00A0\u00A0\u00A0\nschema:author<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Person\/pohar_ron<\/a>> ; # Ron Pohar<\/span>\n\u00A0\u00A0\u00A0\nschema:bookEdition<\/a> \"Version 1.0.<\/span>\" ;\u00A0\u00A0\u00A0\nschema:bookFormat<\/a> schema:EBook<\/a> ;\u00A0\u00A0\u00A0\nschema:contributor<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Organization\/canadian_agency_for_drugs_and_technologies_in_health_rapid_response_service<\/a>> ; # Canadian Agency for Drugs and Technologies in Health. Rapid Response Service,<\/span>\n\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2019<\/span>\" ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"The Eczema Society of Canada has a Seal of Acceptance program \"where products are reviewed to earn recognition from the Eczema Society as an accepted choice for people with sensitive skin.\" This report aimed to summarize the evidence regarding the clinical effectiveness, cost-effectiveness and guidelines of emollient treatments with \"Seal of Acceptance\" from the Eczema Society of Canada for atopic dermatitis. However, no evidence of cost-effectiveness was identified specific to these products, so only evidence of clinical effectiveness and guidelines are reported.<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/9801208886<\/a>> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"Review<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:inLanguage<\/a> \"en<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/worldcat.org\/issn\/1922-8139<\/a>> ; # Rapid response report (Canadian Agency for Drugs and Technologies in Health).<\/span>\n\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/worldcat.org\/issn\/1922-8147<\/a>> ; # CADTH rapid response report: summary with critical appraisal,<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"Emollient treatments for atopic dermatitis : a review of clinical effectiveness, cost-effectiveness, and guidelines<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"1130695297<\/span>\" ;\u00A0\u00A0\u00A0\nschema:url<\/a> <https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544513\/<\/a>> ;\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/1130695297<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Organization\/canadian_agency_for_drugs_and_technologies_in_health_rapid_response_service<\/a>> # Canadian Agency for Drugs and Technologies in Health. Rapid Response Service,<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Organization<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Canadian Agency for Drugs and Technologies in Health. Rapid Response Service,<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Person\/mccormack_suzanne_research_information_specialist<\/a>> # (Research information specialist) Suzanne McCormack<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Person<\/a> ;\u00A0\u00A0\u00A0\nschema:familyName<\/a> \"McCormack<\/span>\" ;\u00A0\u00A0\u00A0\nschema:givenName<\/a> \"Suzanne<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"(Research information specialist) Suzanne McCormack<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Person\/pohar_ron<\/a>> # Ron Pohar<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Person<\/a> ;\u00A0\u00A0\u00A0\nschema:familyName<\/a> \"Pohar<\/span>\" ;\u00A0\u00A0\u00A0\nschema:givenName<\/a> \"Ron<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Ron Pohar<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Place\/canada<\/a>> # Canada.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Canada.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/cost_benefit_analysis<\/a>> # Cost-Benefit Analysis<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Cost-Benefit Analysis<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/dermatitis_atopic_therapy<\/a>> # Dermatitis, Atopic--therapy<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Dermatitis, Atopic--therapy<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/emollients_therapeutic_use<\/a>> # Emollients--therapeutic use<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Emollients--therapeutic use<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/practice_guidelines_as_topic<\/a>> # Practice Guidelines as Topic<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Practice Guidelines as Topic<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9801208886#Topic\/treatment_outcome<\/a>> # Treatment Outcome<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Treatment Outcome<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/id.loc.gov\/vocabulary\/countries\/onc<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\ndcterms:identifier<\/a> \"onc<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/worldcat.org\/issn\/1922-8139<\/a>> # Rapid response report (Canadian Agency for Drugs and Technologies in Health).<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1130695297<\/a>> ; # Emollient treatments for atopic dermatitis : a review of clinical effectiveness, cost-effectiveness, and guidelines<\/span>\n\u00A0\u00A0\u00A0\nschema:issn<\/a> \"1922-8139<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Rapid response report (Canadian Agency for Drugs and Technologies in Health).<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/worldcat.org\/issn\/1922-8147<\/a>> # CADTH rapid response report: summary with critical appraisal,<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1130695297<\/a>> ; # Emollient treatments for atopic dermatitis : a review of clinical effectiveness, cost-effectiveness, and guidelines<\/span>\n\u00A0\u00A0\u00A0\nschema:issn<\/a> \"1922-8147<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"CADTH rapid response report: summary with critical appraisal,<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/1130695297<\/a>>\u00A0\u00A0\u00A0\u00A0a \ngenont:InformationResource<\/a>, genont:ContentTypeGenericResource<\/a> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/www.worldcat.org\/oclc\/1130695297<\/a>> ; # Emollient treatments for atopic dermatitis : a review of clinical effectiveness, cost-effectiveness, and guidelines<\/span>\n\u00A0\u00A0\u00A0\nschema:dateModified<\/a> \"2020-02-15<\/span>\" ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/WorldCat<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Content-negotiable representations<\/p>\n